2013
DOI: 10.3389/fimmu.2013.00133
|View full text |Cite
|
Sign up to set email alerts
|

Advances in T-Cell Epitope Engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 46 publications
0
11
0
Order By: Relevance
“…Indeed, only now are we beginning to understand the pathological consequences of 'clonotype choice', which can determine host outcome in the face of pathogen challenge 33 , 34 , 35 , 36 . Ultimately, the ability to target and amplify 'ideal' precursors from the naive pool, possibly through the use of TCR‐optimized peptides to mobilize specific clonotypes, 37 , 38 , 39 could be a potent advance for biomedicine.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, only now are we beginning to understand the pathological consequences of 'clonotype choice', which can determine host outcome in the face of pathogen challenge 33 , 34 , 35 , 36 . Ultimately, the ability to target and amplify 'ideal' precursors from the naive pool, possibly through the use of TCR‐optimized peptides to mobilize specific clonotypes, 37 , 38 , 39 could be a potent advance for biomedicine.…”
Section: Discussionmentioning
confidence: 99%
“…In this particular setting, however, the retroinverted D peptide was not immunogenic ( Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/JCI91512DS1 ). These observations were not entirely surprising, given the paucity of examples of immunogenic D–amino acid retroinversion T cell agonists described to date ( 22 ).…”
Section: Resultsmentioning
confidence: 95%
“…Based on previous reports of occasional cross-recognition (reviewed in ref. 22 ), we initially examined the ability of a retroinversion of the GILGFVFTL epitope ltfvfglig (lower case type used to denote D–amino acids) to activate an archetypal TRBV19 + ( 24 ) HLA-A2–GILGFVFTL–specific CD8 + T cell clone (ALF3). In this particular setting, however, the retroinverted D peptide was not immunogenic ( Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/JCI91512DS1 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…1,2 The differences in the clinical course of HIV-1 infection may correspond to genetic variances in HIV-1 strains, host genetic variances, or differences in the virus-specific immune responses. [3][4][5][6] HIV infection can be divided into three stages: nonprogressive, chronic, and acute infection. It was found that longterm nonprogressive patients carried undetectable viral loads, had normal CD4 + T cell levels, but had virus-specific cellular responses in peripheral blood and mucosal compartments.…”
Section: H Uman Immunodeficiency Virus (Hiv) Is a Lentivirus That Caumentioning
confidence: 99%